SHPMF Shanghai Pharmaceuticals Holding Co., Ltd — dividend yield, history & ex-dividend dates
Shanghai Pharmaceuticals Holding Co., Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors. Its primary activities include the research, development, production, distribution, and retail of a diverse array of medical and health-related products. The company organizes its operations across four segments: Production, Distribution, Retail, and Others. Its extensive product portfolio encompasses chemical and biochemical medications, traditional Chinese medicines, health products, and medical devices. These target a broad spectrum of therapeutic areas, such as oncology, cerebrocardiovascular conditions, central nervous system disorders, general infections, immunology, digestive and metabolic diseases, and respiratory ailments, offering approximately 700 different drug formulations. Beyond manufacturing, Shanghai Pharmaceuticals provides comprehensive pharmaceutical supply chain solutions. This includes distribution, warehousing, logistics, and various value-added services catering to drug manufacturers and healthcare providers like hospitals, other distributors, and retail pharmacies. The company also manages a substantial retail footprint, operating around 2,000 chain pharmacies across 24 provinces, complemented by an online drug business. Furthermore, its service offerings extend to consulting, asset management, clinical trial support, medical aid programs, educational initiatives for patients and physicians, e-prescription management, and the development of remote and cloud hospital solutions. Established in Shanghai in 1994, where it maintains its headquarters, Shanghai Pharmaceuticals Holding Co., Ltd. operates as a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
Dividend Snapshot
Key Metrics
Current Yield
4.07%
At the Sep 14, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.0595
The most recent payment scaled to a full year by how often it's paid. A $0.25 quarterly dividend annualizes to $1.00.Frequency
I
How often the dividend is paid: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.Rank Score
60.6
As of Sep 14, 2026
Our 0-100 house score blending yield quality, payout sustainability (the trailing-twelve-month payout ratio), profitability (TTM return on equity), valuation (TTM price-to-book) and payment reliability, recomputed daily. Higher means a stronger profile on those factors in our model — a research score, not advice or a recommendation to buy.RSI (14)
0
As of Sep 14, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$1.46 – $1.53
Closes through Sep 08, 2026
The lowest and highest price over the past year — shows where today's price sits in its recent range.Payout Ratio (TTM)
61.50%
12 months to Jun 30, 2026 (Q2 FY2026)
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
14
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (TTM)
0.77
Price as of Sep 14, 2026; latest reported book value
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
Why the Yield Moved (90 Days)
SHPMF's dividend yield rose from 2.33% to 4.07% over the past ~90 days (+1.74 pp). Of that move, +1.74 pp came from changes in the dividend rate and +0.00 pp from the share price ($1.46 on Jun 16, 2026 → $1.46 on Sep 14, 2026). A yield that rises because the price fell is not an improvement in the payout itself.
Yield vs Its Own History
Across 323 daily observations over the past 15 months (through Sep 08, 2026), SHPMF's current yield is higher than approximately 88% of them. Our stored price history for SHPMF covers the past 15 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.0149 I | Regular | - | Sep 16, 2026 | Sep 17, 2026 | Oct 23, 2026 |
| $0.0516 S | Regular | Mar 30, 2026 | Jul 16, 2026 | Jul 16, 2026 | Aug 24, 2026 |
| $0.0516 S | Regular | - | Jul 15, 2026 | Jul 16, 2026 | Aug 24, 2026 |
| $0.0520 S | Regular | - | Jul 14, 2026 | Jul 16, 2026 | Aug 24, 2026 |
| $0.0170 S | Regular | Oct 30, 2025 | Dec 31, 2025 | Dec 31, 2025 | Feb 06, 2026 |
| $0.0404 A | Regular | Mar 27, 2025 | Jul 17, 2025 | Jul 17, 2025 | Aug 25, 2025 |
| $0.0113 S | Regular | Aug 26, 2024 | Sep 19, 2024 | Sep 19, 2024 | Oct 25, 2024 |
| $0.0564 S | Regular | Mar 28, 2024 | Jul 19, 2024 | Jul 19, 2024 | Aug 27, 2024 |
| $0.0849 A | Regular | - | Jul 18, 2023 | Jul 19, 2023 | Aug 28, 2023 |
| $0.0627 A | Regular | - | Jul 20, 2022 | Jul 21, 2022 | Aug 29, 2022 |
| $0.0742 A | Regular | - | Jul 15, 2021 | Jul 16, 2021 | Aug 27, 2021 |
| $0.4812 A | Regular | - | Jul 17, 2020 | Jul 17, 2020 | Aug 21, 2020 |
| $0.4668 A | Regular | - | Jul 12, 2019 | Jul 15, 2019 | Aug 23, 2019 |
| $0.0588 A | Regular | - | Jul 12, 2018 | Jul 13, 2018 | Aug 24, 2018 |
| $0.0528 A | Regular | - | Jul 12, 2017 | Jul 13, 2017 | Aug 21, 2017 |
| $0.3887 A | Regular | - | Jul 15, 2016 | - | - |
| $0.3676 A | Regular | - | Jun 17, 2015 | - | - |
| $0.3274 A | Regular | - | May 22, 2014 | - | - |
| $0.3015 A | Regular | - | Jun 19, 2013 | - | - |
| $0.0251 A | Regular | Mar 30, 2012 | Jun 14, 2012 | Jun 15, 2012 | Jul 25, 2012 |
Peer Comparison
Selected Medical - Distribution dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| MEPDF | MediPal Holdings Corporation | 3.05% | 5.7% | 4 yrs | 78 |
| ARHCF | Alfresa Holdings Corporation | 3.33% | -1.9% | 0 yrs | 78 |
| IUSDF | AS ONE Corporation | 3.05% | 15.1% | 5 yrs | 77 |
| ALFRY | Alfresa Holdings Corporation | 3.32% | -2.0% | 0 yrs | 74 |
Related Guides & Lists
SHPMF dividend — frequently asked questions
Does Shanghai Pharmaceuticals Holding Co., Ltd pay a dividend?
Yes. Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) currently pays a dividend. The annualized dividend is about $0.06 per share, a yield of approximately 4.07%.
What is Shanghai Pharmaceuticals Holding Co., Ltd's dividend yield?
Shanghai Pharmaceuticals Holding Co., Ltd's dividend yield is approximately 4.07%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
When is Shanghai Pharmaceuticals Holding Co., Ltd's next ex-dividend date?
The next ex-dividend date on record for Shanghai Pharmaceuticals Holding Co., Ltd is September 16, 2026. The associated payment is $0.0149 per share; you must own the shares before the ex-dividend date to receive it.
How long has Shanghai Pharmaceuticals Holding Co., Ltd paid dividends?
Shanghai Pharmaceuticals Holding Co., Ltd has 14 years of dividend payments on record.
Data updated Sep 14, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.